510(k) Report

510(k) · Cleared

Cleared

Thulium Fiber Laser System (TFL-A); Thulium Fiber Laser System (TFL-B)

K252787510(k) TraditionalCleared Nov 24, 202583-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Guangzhou Potent Medical Equipment Joint-Stock Co., Ltd. · GEX Powered Laser Surgical Instrument

Cleared on Nov 24, 2025 as substantially equivalent to K210142 (Quanta System Spa, 2021) after an 83-day review. Its family tree reaches back 1 generation to 2021.

Decided
Nov 24, 2025
Review
83 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K210142 (2021). No later device cites it as a predicate yet.

K210142 · Fiber Dust · Quanta System Spa · 20212020202220242026
K210142 · Fiber Dust · Quanta System Spa · 20210
  1. Root · 1 generation backK210142 Fiber DustQuanta System Spa · 2021
  2. This deviceK252787 Thulium Fiber Laser System (TFL-A); Thulium Fiber Laser System (TFL-B)Guangzhou Potent Medical Equipment Joint-Stock Co., Ltd. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K210142Fiber DustQuanta System Spa2021—
0 (this device)K252787Thulium Fiber Laser System (TFL-A); Thulium Fiber Laser System (TFL-B)Guangzhou Potent Medical Equipment Joint-Stock Co., Ltd.2025—
FIG. 1 — Lineage of K252787, 2021–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K210142Fiber Dust
Summary page 6
…Reference Devices Type Device Manufacturer 510(k) Number Predicate Fiber Dust Quanta System SpA K210142 1/6 Device Desc…
Quanta System Spa2021—

Also cleared against K210142: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 3 other devices also cite its predicate K210142.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The Thulium Fiber Laser System is intended for incision, excision, resection, ablation, coagulation, hemostasis and vaporization of soft tissue, in the following indications: urology, lithotripsy, gastroenterological surgery and gynecological surgery. Urology • Ablation of Benign Prostatic Hyperplasia (BPH) • Laser Resection of the Prostate (LRP) • Laser Enucleation of the Prostate (LEP) • Laser Ablation of the Prostate (LAP) • Transurethral Incision of…

Read the full statement (260 words)

The Thulium Fiber Laser System is intended for incision, excision, resection, ablation, coagulation, hemostasis and vaporization of soft tissue, in the following indications: urology, lithotripsy, gastroenterological surgery and gynecological surgery.

Urology

• Ablation of Benign Prostatic Hyperplasia (BPH)

• Laser Resection of the Prostate (LRP)

• Laser Enucleation of the Prostate (LEP)

• Laser Ablation of the Prostate (LAP)

• Transurethral Incision of the Prostate (TUIP)

• Condylomas

• Urethral strictures

• Lesions of external genitalia

• Bladder neck incisions (BNI)

• Ablation and resection of bladder tumors, urethral tumors, and ureteral tumors

• Endoscopic fragmentation of urethral, ureteral, bladder, and renal calculi

• Treatment of distal impacted fragments remaining in the ureters following lithotripsy

Lithotripsy and Percutaneous Urinary Lithotripsy

• Endoscopic fragmentation of urethral, ureteral, bladder and renal calculi including cystine, calcium oxalate monohydrate and calcium oxalate dehydrate stones

• Endoscopic fragmentation of renal calculi

• Treatment of distal impacted fragments of steinstrasse when guide wire cannot be passed

Gastroenterology

open and endoscopic gastroenterology surgery (incision, excision, resection, ablation, vaporization, coagulation and haemostasis) including:

• Appendectomy

• Angiodysplasia

• Polyps

• Colorectal cancer

• Biopsy

• Telangiectasias

• Gall Bladder calculi

• Telangiectasias ofthe osler-weber-Renu disease

• Biliary/Bile duct calculi vascular Malformation

• Ulcers

• Gastritis

• Gastric ulcers

• Esophagitis

• Duodenal ulcers

• Esophageal ulcers

• Non Bleeding ulcers

• Varices

• Pancreatitis

• Colitis

• Haemorrhoids

• Mallory-weiss tear

• Cholecystectomy

• Gastric Erosions

• Benign and Malignant Neoplasm

Gynecology

Open and laparoscopic gynecological surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K252787: Thulium Fiber Laser System (TFL-A); Thulium Fiber Laser System (TFL-B).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K252787

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026